Literature DB >> 16319329

Effects of exacerbations and seasonality on exhaled nitric oxide in COPD.

A Bhowmik1, T A R Seemungal, G C Donaldson, J A Wedzicha.   

Abstract

Exhaled nitric oxide (eNO) appears to be associated with airway inflammation seen in chronic obstructive pulmonary disease (COPD). The present authors studied the effects of exacerbation, season, temperature and pollution on eNO. eNO was measured seasonally and at exacerbations in 79 outpatients suffering from COPD (mean forced expiratory volume in one second=42%). The effects of exacerbation symptoms, physiological and environmental parameters were analysed. Stable eNO levels were correlated positively with arterial oxygen tension. Median levels were found to be lower in smokers (5.3 ppb) than in ex- or nonsmokers (6.8 ppb). Levels were higher during October to December (6.9 ppb) than in April to June (4.6 ppb). Levels were also higher during 68 exacerbations in 38 patients (7.4 ppb) than in stable conditions (5.4 ppb), independent of the effects of smoking. The rise in eNO was greater in exacerbations that were associated with colds, a sore throat or dyspnoea combined with a cold. In conclusion, exhaled nitric oxide levels were higher in colder weather and in the autumn, perhaps related to the increased prevalence of viral infection at this time of year. The levels were lower in more severe chronic obstructive pulmonary disease. Exhaled nitric oxide levels were raised at the onset of exacerbation, particularly in the presence of a cold.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16319329     DOI: 10.1183/09031936.05.00047305

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

Review 1.  Noninvasive effects measurements for air pollution human studies: methods, analysis, and implications.

Authors:  Jaime Mirowsky; Terry Gordon
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-01-21       Impact factor: 5.563

Review 2.  Arginase and pulmonary diseases.

Authors:  Harm Maarsingh; Tonio Pera; Herman Meurs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-24       Impact factor: 3.000

3.  Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.

Authors:  Renate Jonker; Nicolaas Ep Deutz; Marcia L Erbland; Paula J Anderson; Mariëlle Pkj Engelen
Journal:  Am J Clin Nutr       Date:  2016-05-04       Impact factor: 7.045

4.  Repeatability of exhaled nitric oxide measurements in patients with COPD.

Authors:  Annamari Rouhos; Annette Kainu; Päivi Piirilä; Seppo Sarna; Ari Lindqvist; Jouko Karjalainen; Anssi R A Sovijärvi
Journal:  Clin Physiol Funct Imaging       Date:  2010-09-23       Impact factor: 2.273

5.  A retrospective study of the impact of a telephone alert service (Healthy Outlook) on hospital admissions for patients with chronic obstructive pulmonary disease.

Authors:  Christophe Sarran; David Halpin; Mark L Levy; Samantha Prigmore; Patrick Sachon
Journal:  NPJ Prim Care Respir Med       Date:  2014-10-23       Impact factor: 2.871

6.  Seasonality, ambient temperatures and hospitalizations for acute exacerbation of COPD: a population-based study in a metropolitan area.

Authors:  Pere Almagro; Carme Hernandez; Pable Martinez-Cambor; Ricard Tresserras; Joan Escarrabill
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-08

7.  Acute effects of ambient temperature and particulate air pollution on fractional exhaled nitric oxide: A panel study among diabetic patients in Shanghai, China.

Authors:  Huichu Li; Hongjian Bai; Changyuan Yang; Renjie Chen; Cuicui Wang; Zhuohui Zhao; Haidong Kan
Journal:  J Epidemiol       Date:  2017-06-20       Impact factor: 3.211

Review 8.  Pulmonary biomarkers in COPD exacerbations: a systematic review.

Authors:  Angela Koutsokera; Konstantinos Kostikas; Laurent P Nicod; Jean-William Fitting
Journal:  Respir Res       Date:  2013-10-21

Review 9.  Role of alveolar macrophages in chronic obstructive pulmonary disease.

Authors:  Ross Vlahos; Steven Bozinovski
Journal:  Front Immunol       Date:  2014-09-10       Impact factor: 7.561

Review 10.  Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations.

Authors:  Andrew I Ritchie; Jadwiga A Wedzicha
Journal:  Clin Chest Med       Date:  2020-09       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.